Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Surgical Treatment for Locally Advanced (T4) Squamous Cell Carcinoma of the Thoracic Esophagus

Surgical Treatment for Locally Advanced (T4) Squamous Cell Carcinoma of the Thoracic Esophagus 10.1007/s00455-002-0069-9 Dysphagia © Springer-Verlag New York Inc. 2002 10.1007/s00455-002-0069-9 Contact Information 1 1 1 1 Mitsuo Tachibana MD , Dipok Kumar Dhar MD , Shoichi Kinugasa MD , Hiroshi Yoshimura MD , 1 1 1 1 1 1 Muneaki Shibakita MD , Satoshi Ohno MD , Shuhei Ueda MD , Toshiyuki Fujii MD , Hitoshi Kohno MD and Naofumi Nagasue MD (1) Second Department of Surgery, Shimane Medical University, Enya-cho 89-1, Izumo 693-8501, Shimane, Japan Mitsuo Tachibana Contact Information Email: [email protected] Abstract It is still difficult to decide on the treatment modalities for advanced esophageal carcinoma when the prognostic factors of T4 esophageal cancer are not fully understood. In this article, we report that among 71 patients with T4 thoracic esophageal cancer, 49 underwent esophagectomy, 9 had curative resection (R0 group), and 40 had palliative resection (R1/2 group). A total of 22 patients had palliative treatments: bypass in 5 (bypass group), gastrostomy or jejunostomy in 6 (stoma group), and radiochemotherapy alone in 11 (nonoperation group). Clinicopathologic characteristics were retrospectively investigated. Treatment-related deaths occurred in 7 (10%): none in R0, 3 (8%) in R1/2, 3 (60%) in bypass, and 1 (17%) in stoma group. Swallowing was improved in 50 (70%) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Dysphagia Springer Journals

Surgical Treatment for Locally Advanced (T4) Squamous Cell Carcinoma of the Thoracic Esophagus

Download PDF
11 pages

Loading next page...
 
/lp/springer-journals/surgical-treatment-for-locally-advanced-t4-squamous-cell-carcinoma-of-KWBxgEdz02

References (22)

Publisher
Springer Journals
Copyright
Copyright © 2002 by Springer-Verlag New York Inc.
Subject
Medicine & Public Health; Otorhinolaryngology; Imaging / Radiology; Gastroenterology; Hepatology
ISSN
0179-051X
eISSN
1432-0460
DOI
10.1007/s00455-002-0069-0
pmid
12355140
Publisher site
See Article on Publisher Site

Abstract

10.1007/s00455-002-0069-9 Dysphagia © Springer-Verlag New York Inc. 2002 10.1007/s00455-002-0069-9 Contact Information 1 1 1 1 Mitsuo Tachibana MD , Dipok Kumar Dhar MD , Shoichi Kinugasa MD , Hiroshi Yoshimura MD , 1 1 1 1 1 1 Muneaki Shibakita MD , Satoshi Ohno MD , Shuhei Ueda MD , Toshiyuki Fujii MD , Hitoshi Kohno MD and Naofumi Nagasue MD (1) Second Department of Surgery, Shimane Medical University, Enya-cho 89-1, Izumo 693-8501, Shimane, Japan Mitsuo Tachibana Contact Information Email: [email protected] Abstract It is still difficult to decide on the treatment modalities for advanced esophageal carcinoma when the prognostic factors of T4 esophageal cancer are not fully understood. In this article, we report that among 71 patients with T4 thoracic esophageal cancer, 49 underwent esophagectomy, 9 had curative resection (R0 group), and 40 had palliative resection (R1/2 group). A total of 22 patients had palliative treatments: bypass in 5 (bypass group), gastrostomy or jejunostomy in 6 (stoma group), and radiochemotherapy alone in 11 (nonoperation group). Clinicopathologic characteristics were retrospectively investigated. Treatment-related deaths occurred in 7 (10%): none in R0, 3 (8%) in R1/2, 3 (60%) in bypass, and 1 (17%) in stoma group. Swallowing was improved in 50 (70%)

Journal

Dysphagia – Springer Journals

Published: Dec 1, 2002

There are no references for this article.